BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22537986)

  • 1. Intra-cisternal vaccination induces high-level protection against Neospora caninum infection in mice.
    Debache K; Hemphill A
    Vaccine; 2012 Jun; 30(28):4209-15. PubMed ID: 22537986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites.
    Debache K; Guionaud C; Alaeddine F; Mevissen M; Hemphill A
    Int J Parasitol; 2008 Oct; 38(12):1455-63. PubMed ID: 18495126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal and intra-nasal vaccination of mice with three distinct recombinant Neospora caninum antigens results in differential effects with regard to protection against experimental challenge with Neospora caninum tachyzoites.
    Debache K; Guionaud C; Alaeddine F; Hemphill A
    Parasitology; 2010 Feb; 137(2):229-40. PubMed ID: 19835644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune enhancement of a novel soy lecithin/β-glucans based adjuvant on native Neospora caninum tachyzoite extract vaccine in mice.
    Mansilla FC; Franco-Mahecha OL; Lavoria MÁ; Moore DP; Giraldez AN; Iglesias ME; Wilda M; Capozzo AV
    Vaccine; 2012 Feb; 30(6):1124-31. PubMed ID: 22178728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant.
    Cannas A; Naguleswaran A; Müller N; Gottstein B; Hemphill A
    J Parasitol; 2003 Feb; 89(1):44-50. PubMed ID: 12659301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of adjuvant and antigen dose on protection induced by an inactivated whole vaccine against Neospora caninum infection in mice.
    Rojo-Montejo S; Collantes-Fernández E; Regidor-Cerrillo J; Rodríguez-Bertos A; Prenafeta A; Gomez-Bautista M; Ortega-Mora LM
    Vet Parasitol; 2011 Feb; 175(3-4):220-9. PubMed ID: 21067865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of mice with chitosan nanogel-associated recombinant NcPDI against challenge infection with Neospora caninum tachyzoites.
    Debache K; Kropf C; Schütz CA; Harwood LJ; Käuper P; Monney T; Rossi N; Laue C; McCullough KC; Hemphill A
    Parasite Immunol; 2011 Feb; 33(2):81-94. PubMed ID: 21226721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of female BALB/c mice with Neospora cyclophilin and/or NcSRS2 elicits specific antibody response and prevents against challenge infection by Neospora caninum.
    Tuo W; Zhao Y; Zhu D; Jenkins MC
    Vaccine; 2011 Mar; 29(13):2392-9. PubMed ID: 21281689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of immunization with inactivated whole tachyzoites versus a tachyzoite-bradyzoite mixture against neosporosis in mice.
    Rojo-Montejo S; Collantes-Fernández E; Rodríguez-Marcos S; Pérez-Zaballos F; López-Pérez I; Prenafeta A; Ortega-Mora LM
    Parasitology; 2011 Sep; 138(11):1372-83. PubMed ID: 21810300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins.
    Vemulapalli R; Sanakkayala N; Gulani J; Schurig GG; Boyle SM; Lindsay DS; Sriranganathan N
    Vet Parasitol; 2007 Sep; 148(3-4):219-30. PubMed ID: 17651896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites.
    Debache K; Alaeddine F; Guionaud C; Monney T; Müller J; Strohbusch M; Leib SL; Grandgirard D; Hemphill A
    Int J Parasitol; 2009 Oct; 39(12):1373-84. PubMed ID: 19447110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with gamma-irradiated Neospora caninum tachyzoites protects mice against acute challenge with N. caninum.
    Ramamoorthy S; Lindsay DS; Schurig GG; Boyle SM; Duncan RB; Vemulapalli R; Sriranganathan N
    J Eukaryot Microbiol; 2006; 53(2):151-6. PubMed ID: 16579818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to Neospora caninum in naturally infected heifers and heifers vaccinated with inactivated antigen during the second trimester of gestation.
    Moore DP; Leunda MR; Zamorano PI; Odeón AC; Romera SA; Cano A; de Yaniz G; Venturini MC; Campero CM
    Vet Parasitol; 2005 Jun; 130(1-2):29-39. PubMed ID: 15893067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with microneme protein NcMIC4 increases mortality in mice inoculated with Neospora caninum.
    Srinivasan S; Mueller J; Suana A; Hemphill A
    J Parasitol; 2007 Oct; 93(5):1046-55. PubMed ID: 18163338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection.
    Monney T; Debache K; Grandgirard D; Leib SL; Hemphill A
    Vaccine; 2012 Oct; 30(46):6588-94. PubMed ID: 22940381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of protective activities of Neospora caninum bradyzoite antigens, NcBAG1, NcBSR4, NcMAG1, and NcSAG4, in a mouse model of acute parasitic infection.
    Uchida M; Nagashima K; Akatsuka Y; Murakami T; Ito A; Imai S; Ike K
    Parasitol Res; 2013 Feb; 112(2):655-63. PubMed ID: 23229317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1.
    Alaeddine F; Keller N; Leepin A; Hemphill A
    J Parasitol; 2005 Jun; 91(3):657-65. PubMed ID: 16108562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inoculation of Balb/c mice with live attenuated tachyzoites protects against a lethal challenge of Neospora caninum.
    Bartley PM; Wright S; Chianini F; Buxton D; Innes EA
    Parasitology; 2008 Jan; 135(Pt 1):13-21. PubMed ID: 17767798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low efficacy of NcGRA7, NcSAG4, NcBSR4 and NcSRS9 formulated in poly-ε-caprolactone against Neospora caninum infection in mice.
    Jiménez-Ruiz E; Alvarez-García G; Aguado-Martínez A; Salman H; Irache JM; Marugán-Hernández V; Ortega-Mora LM
    Vaccine; 2012 Jul; 30(33):4983-92. PubMed ID: 22640942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG-ODN combined with Neospora caninum lysate, but not with excreted-secreted antigen, enhances protection against infection in mice.
    Ribeiro DP; Freitas MM; Cardoso MR; Pajuaba AC; Silva NM; Mineo TW; Silva JS; Mineo JR; Silva DA
    Vaccine; 2009 Apr; 27(19):2570-9. PubMed ID: 19428863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.